Expert opinion on the use of cladribine tablets in clinical practice

BACKGROUND: Gaps in current product labels and a lack of detailed clinical guidelines leaves clinicians’ questions on the practical management of patients receiving cladribine tablets for the treatment of relapsing multiple sclerosis (MS) unanswered. We describe a consensus-based programme led by in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sørensen, Per Soelberg, Centonze, Diego, Giovannoni, Gavin, Montalban, Xavier, Selchen, Daniel, Vermersch, Patrick, Wiendl, Heinz, Yamout, Bassem, Salloukh, Hashem, Rieckmann, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318823/
https://www.ncbi.nlm.nih.gov/pubmed/32636933
http://dx.doi.org/10.1177/1756286420935019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318823/
https://www.ncbi.nlm.nih.gov/pubmed/32636933
http://dx.doi.org/10.1177/1756286420935019

Ejemplares similares